Medical devices, healthcare technology and the business of care
PMA SUPPLEMENT · P100018/S052

PIPELINE EMBOLIZATION DEVICE

Micro Therapeutics, Inc. d/b/a ev3 Neurovascular · Decision date Feb 20, 2026

FDA DECISIONP100018/S052

What did the FDA approve?

FDA records P100018/S052 as a supplement to PMA P100018, with the supplement type “Real-Time Process”. The recorded decision is approval, dated Feb 20, 2026.

FDA approval order statement

Approval of claims regarding reduced material thrombogenicity of a proprietary surface modification for the Pipeline Flex Embolization Device with Shield Technology and Pipeline Vantage Embolization Device with Shield Technology supported by acute benchtop in-vitro testing.
Regulatory pathway
PMA supplement
Supplement type
Real-Time Process
Clinical specialty
Neurology
Decision date
Feb 20, 2026
FDA change category
Labeling Change - Indications/instructions/shelf life/tradename

FDA source record

Regulatory record facts

Identifier
P100018/S052
Regulatory pathway
PMA supplement
Product code
OUT
Decision code
APPR
Decision date
Feb 20, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Intracranial aneurysm flow diverter.

Product code
OUT
FDA device class
3

Review the original FDA PMA listing for the original approval scope and linked supplements.

FDA decision timeline

  1. P100018/S048 · Related supplement

    Pipeline Vantage Embolization Device with Shield Technology

  2. P100018/S052 received

    Application receipt date recorded by FDA.

  3. P100018/S052 · FDA decision

    Real-Time Process

  4. P100018/S053 · Related supplement

    Pipeline Flex Embolization Device (Pipeline Flex); Pipeline Flex Embolization Device with Shield Technology (Pipelin

  5. P100018/S054 · Related supplement

    Pipeline Flex Embolization Device with Shield Technology (Pipeline Shield); Pipeline Vantage Embolization Device wit

  6. P100018/S055 · Related supplement

    Pipeline Flex Embolization Device (Pipeline Flex); Pipeline Flex Embolization Device with Shield Technology (Pipelin

Timeline entries are records held by MedtechLedger for P100018. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P100018

Explore the linked device profile

Other records with product code OUT

Product / regulatory recordCompanyPathwayDecision dateSource
Stryker NeurovascularPMA supplementAug 28, 2026FDA
Stryker NeurovascularPMA supplementJun 26, 2026FDA
Microvention, Inc.PMA supplementNov 2, 2025FDA
Microvention, Inc.PMA supplementSep 20, 2025FDA
FRED X SystemP180027/S014
Microvention, Inc.PMA supplementSep 18, 2025FDA

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.

FDA describes the real-time supplement process as a review route for minor changes to a device, including certain design, software, sterilization or labeling changes.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Micro Therapeutics, Inc. d/b/a ev3 Neurovascular

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
9775 Toledo Way, Irvine, CA, 92618

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records